Sven Mahner Department of Obstetrics and Gynecology University Hospital, Ludwig-Maximilian-University (LMU) Munich Biography Publications Institution JoVE Articles Sven Mahner has not added a biography. If you are Sven Mahner and would like to personalize this page please email our Author Liaison for assistance. Publications KLF11 is an Independent Negative Prognostic Factor for Breast Cancer from a Cohort Study and Induces Proliferation and Inhibits Apoptosis in Vitro Breast Cancer (Tokyo, Japan). Sep, 2023 | Pubmed ID: 37199905 Nuclear Receptor Co-repressor NCOR2 and Its Relation to GPER with Prognostic Impact in Ovarian Cancer Journal of Cancer Research and Clinical Oncology. Sep, 2023 | Pubmed ID: 37131060 PLA2G7/PAF-AH As Potential Negative Regulator of the Wnt Signaling Pathway Mediates Protective Effects in BRCA1 Mutant Breast Cancer International Journal of Molecular Sciences. Jan, 2023 | Pubmed ID: 36614323 Lower HLA-G Levels in Extravillous Trophoblasts of Human Term Placenta in Gestational Diabetes Mellitus Than in Normal Controls Histochemistry and Cell Biology. Jun, 2023 | Pubmed ID: 36538164 Risk of Postpartum Depressive Symptoms is Influenced by Psychological Burden Related to the COVID-19 Pandemic and Dependent of Individual Stress Coping Archives of Gynecology and Obstetrics. Dec, 2023 | Pubmed ID: 36482113 Prostaglandin E2 Receptor EP1 Expression in Vulvar Cancer Journal of Cancer Research and Clinical Oncology. Jul, 2023 | Pubmed ID: 36436093 Pelvic Inlet Area is Associated with Birth Mode Acta Obstetricia Et Gynecologica Scandinavica. Jan, 2023 | Pubmed ID: 36320156 [Not Available] MMW Fortschritte Der Medizin. Sep, 2022 | Pubmed ID: 36123455 MUC1 (CA27.29) Before and After Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients Cancers. Mar, 2022 | Pubmed ID: 35406491 Effects of SARS-CoV-2 on Prenatal Lung Growth Assessed by Fetal MRI The Lancet. Respiratory Medicine. Apr, 2022 | Pubmed ID: 35305309 Distress in Hospitalized Cancer Patients: Associations with Personality Traits, Clinical and Psychosocial Characteristics Psycho-oncology. May, 2022 | Pubmed ID: 34894364 Regulation of Epigenetic Modifications in the Placenta During Preeclampsia: PPARγ Influences H3K4me3 and H3K9ac in Extravillous Trophoblast Cells International Journal of Molecular Sciences. Nov, 2021 | Pubmed ID: 34830351 The Platelet-Activating Factor Receptor's Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine Cells. Sep, 2021 | Pubmed ID: 34571986 Prostaglandin E2 Receptor 4 (EP4) Affects Trophoblast Functions Via Activating the CAMP-PKA-pCREB Signaling Pathway at the Maternal-Fetal Interface in Unexplained Recurrent Miscarriage International Journal of Molecular Sciences. Aug, 2021 | Pubmed ID: 34502044 Functional Analysis of Non-Genetic Resistance to Platinum in Epithelial Ovarian Cancer Reveals a Role for the MBD3-NuRD Complex in Resistance Development Cancers. Jul, 2021 | Pubmed ID: 34359703 Cytoplasmic Localization of RXRα Determines Outcome in Breast Cancer Cancers. Jul, 2021 | Pubmed ID: 34359656 Diagnostic Workup for Endometrioid Borderline Ovarian Tumors (eBOT) Requires Histopathological Evaluation of the Uterus Journal of Ovarian Research. Jul, 2021 | Pubmed ID: 34233728 Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer As a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway Biomedicines. Jun, 2021 | Pubmed ID: 34206491 Well-being During COVID-19 Pandemic: A Comparison of Individuals with Minoritized Sexual and Gender Identities and Cis-heterosexual Individuals PloS One. 2021 | Pubmed ID: 34101746 Cytoplasmic LXR Expression is an Independent Marker of Poor Prognosis for Patients with Early Stage Primary Breast Cancer Journal of Cancer Research and Clinical Oncology. Sep, 2021 | Pubmed ID: 34085098 Breast Adipose Tissue Macrophages (BATMs) Have a Stronger Correlation with Breast Cancer Survival Than Breast Tumor Stroma Macrophages (BTSMs) Breast Cancer Research : BCR. Apr, 2021 | Pubmed ID: 33849622 EP4 As a Negative Prognostic Factor in Patients with Vulvar Cancer Cancers. Mar, 2021 | Pubmed ID: 33808776 Epigenetic Modification Via H3K4me3 and H3K9ac in Human Placenta is Reduced in Preeclampsia Journal of Reproductive Immunology. Feb, 2021 | Pubmed ID: 33662848 The Prognostic Impact of Retinoid X Receptor and Thyroid Hormone Receptor Alpha in Unifocal Vs. Multifocal/Multicentric Breast Cancer International Journal of Molecular Sciences. Jan, 2021 | Pubmed ID: 33478016 Nuclear Enolase-1/ MBP-1 Expression and Its Association with the Wnt Signaling in Epithelial Ovarian Cancer Translational Oncology. Jan, 2021 | Pubmed ID: 33069100 Interleukin 15 and Eotaxin Correlate with the Outcome of Breast Cancer Patients Vice Versa Independent of CTC Status Archives of Gynecology and Obstetrics. Jan, 2021 | Pubmed ID: 32929618 β-arrestin 2 Is a Prognostic Factor for Survival of Ovarian Cancer Patients Upregulating Cell Proliferation Frontiers in Endocrinology. 2020 | Pubmed ID: 33042017 Potential of Platinum-resensitization by Wnt Signaling Modulators As Treatment Approach for Epithelial Ovarian Cancer Journal of Cancer Research and Clinical Oncology. Oct, 2020 | Pubmed ID: 32681294 Cytoplasmic VDR Expression As an Independent Risk Factor for Ovarian Cancer Histochemistry and Cell Biology. Oct, 2020 | Pubmed ID: 32572587 M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis Cells. May, 2020 | Pubmed ID: 32429133 High Galectin-7 and Low Galectin-8 Expression and the Combination of Both Are Negative Prognosticators for Breast Cancer Patients Cancers. Apr, 2020 | Pubmed ID: 32290551 Sex-specific Epigenetic Gene Activation Profiles Are Differentially Modulated in Human Placentas Affected by Intrauterine Growth Restriction Journal of Reproductive Immunology. Jun, 2020 | Pubmed ID: 32289580 Cytoplasmic PPARγ is a Marker of Poor Prognosis in Patients with Cox-1 Negative Primary Breast Cancers Journal of Translational Medicine. Feb, 2020 | Pubmed ID: 32085795 The Prostaglandin Receptor EP2 Determines Prognosis in EP3-negative and Galectin-3-high Cervical Cancer Cases Scientific Reports. Jan, 2020 | Pubmed ID: 31980713 Cytoplasmic and Nuclear Forms of Thyroid Hormone Receptor β1 Are Inversely Associated with Survival in Primary Breast Cancer International Journal of Molecular Sciences. Jan, 2020 | Pubmed ID: 31947762 Higher CCL22+ Cell Infiltration is Associated with Poor Prognosis in Cervical Cancer Patients Cancers. Dec, 2019 | Pubmed ID: 31842422 Hormone Receptor Expression in Multicentric/Multifocal Versus Unifocal Breast Cancer: Especially the VDR Determines the Outcome Related to Focality International Journal of Molecular Sciences. Nov, 2019 | Pubmed ID: 31731733 Correlation of the Aryl Hydrocarbon Receptor with FSHR in Ovarian Cancer Patients International Journal of Molecular Sciences. Jun, 2019 | Pubmed ID: 31212758 Lymph Node Dissection in Endometrial Cancer and Clinical Outcome: A Population-based Study in 5546 Patients Gynecologic Oncology. Jul, 2019 | Pubmed ID: 31027900 The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status International Journal of Molecular Sciences. Feb, 2019 | Pubmed ID: 30813617 Prognostic Relevance of RIP140 and ERβ Expression in Unifocal Versus Multifocal Breast Cancers: a Preliminary Report International Journal of Molecular Sciences. Jan, 2019 | Pubmed ID: 30669416 Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer International Journal of Molecular Sciences. Jan, 2019 | Pubmed ID: 30642093 Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer Patients International Journal of Molecular Sciences. Dec, 2018 | Pubmed ID: 30597961 Histone H3 Lysine 9 Acetylation is Downregulated in GDM Placentas and Calcitriol Supplementation Enhanced This Effect International Journal of Molecular Sciences. Dec, 2018 | Pubmed ID: 30558244 [Hallmarks in Obstetrics and Gynecology] MMW Fortschritte Der Medizin. Nov, 2018 | Pubmed ID: 30421184 The Genetic Landscape of 87 Ovarian Germ Cell Tumors Gynecologic Oncology. Oct, 2018 | Pubmed ID: 30170975 PPARγ Expression Is Diminished in Macrophages of Recurrent Miscarriage Placentas International Journal of Molecular Sciences. Jun, 2018 | Pubmed ID: 29949879 Evaluation of Reproductive Concerns and Biographical Impact of Breast Cancer in Young Patients Breast Care (Basel, Switzerland). Apr, 2018 | Pubmed ID: 29887790 Prostaglandin E Receptor 3 Signaling is Induced in Placentas with Unexplained Recurrent Pregnancy Losses Endocrine Connections. May, 2018 | Pubmed ID: 29700097 Dopamine Synthesis and Dopamine Receptor Expression Are Disturbed in Recurrent Miscarriages Endocrine Connections. May, 2018 | Pubmed ID: 29686031 Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9 International Journal of Molecular Sciences. Jan, 2018 | Pubmed ID: 29361803 Role of Placental VDR Expression and Function in Common Late Pregnancy Disorders International Journal of Molecular Sciences. Nov, 2017 | Pubmed ID: 29113124 Vitamin D and VDR in Gynecological Cancers-A Systematic Review International Journal of Molecular Sciences. Nov, 2017 | Pubmed ID: 29113037 Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases International Journal of Molecular Sciences. Jul, 2017 | Pubmed ID: 28758928 The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients International Journal of Molecular Sciences. Jul, 2017 | Pubmed ID: 28753926 Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients International Journal of Molecular Sciences. Jun, 2017 | Pubmed ID: 28594391 Local Resection of Primary Tumor in Upfront Stage IV Breast Cancer Breast Care (Basel, Switzerland). Dec, 2016 | Pubmed ID: 28228708 Prognostic and Predictive Effects of Primary Versus Secondary Platinum Resistance for Bevacizumab Treatment for Platinum-resistant Ovarian Cancer in the AURELIA Trial Annals of Oncology : Official Journal of the European Society for Medical Oncology. Sep, 2016 | Pubmed ID: 27287207 Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer Fabian Trillsch*1,2, Juliane Reichenbach*1, Bastian Czogalla1, Fabian Kraus1, Alexander Burges1, Sven Mahner1,2, Mirjana Kessler1,2 1Department of Obstetrics and Gynecology, University Hospital, Ludwig-Maximilian-University (LMU) Munich, 2German Cancer Consortium (DKTK), Partner site Munich (LMU), a partnership between the German Cancer Research Center (DKFZ) and the University Hospital of LMU Munich JoVE 66467 Cancer Research
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer Fabian Trillsch*1,2, Juliane Reichenbach*1, Bastian Czogalla1, Fabian Kraus1, Alexander Burges1, Sven Mahner1,2, Mirjana Kessler1,2 1Department of Obstetrics and Gynecology, University Hospital, Ludwig-Maximilian-University (LMU) Munich, 2German Cancer Consortium (DKTK), Partner site Munich (LMU), a partnership between the German Cancer Research Center (DKFZ) and the University Hospital of LMU Munich JoVE 66467 Cancer Research